Radiotherapy in Association With Cetuximab in Patients Treated for an Epidermoid Cancer
Completed
57 enrolled
Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
Phase 2 Completed
40 enrolled 20 charts
Priming Immunotherapy in Advanced Disease With Radiation
Phase 2 Completed
76 enrolled 9 charts
KEYNOTE-412
Phase 3 Completed
804 enrolled 20 charts
Radiotherapy, Carboplatin/Paclitaxel and Nivolumab for High Risk HPV-related Head and Neck Cancer
Phase 2 Completed
26 enrolled 13 charts
Nivolumab + Chemoradiation in Stage II-IVB Nasopharyngeal Carcinoma (NPC)
Phase 2 Completed
40 enrolled 14 charts
Low-dose Radiotherapy Plus Tislelizumab in Combination With Afatinib for Neoadjuvant Treatment of Surgically Resectable Head and Neck Squamous Carcinoma
Phase 1 Completed
9 enrolled
Lactobacillus Reuteri Alleviates Oral Mucositis in Patients Undergoing Radiotherapy for Malignant Head and Neck Tumors
Phase 2 Completed
160 enrolled
UPFRONT-NECK
Phase 3 Completed
65 enrolled
AACER
Phase 2 Completed
53 enrolled
REPORT
Phase 1/2 Completed
20 enrolled
Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer
Phase 2 Completed
91 enrolled 11 charts
Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer
Phase 1 Completed
41 enrolled
Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer
Phase 1 Completed
13 enrolled
Safety Study of Afatinib and Postoperative Radiation Therapy to Treat Head and Neck Cancer
Phase 1 Completed
29 enrolled
sEphB4-HSA With RT+Chemo or Cetux in Patients With Intermediate to High Risk LAHNSCC
Phase 1 Completed
3 enrolled
Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck Cancer
Phase 2 Completed
31 enrolled 8 charts
Arginine/Omega-3 Fatty Acids/Nucleotides Nutritional Supplement in Treating Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy
Phase 2 Completed
46 enrolled
Adjuvant De-Escalated Radiation + Adjuvant Nivolumab for Intermediate-High Risk P16+ Oropharynx Cancer
Phase 2 Completed
40 enrolled 69 charts
PREVLAR
Phase 2 Completed
53 enrolled 15 charts
Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck Cancer
Phase 2 Completed
30 enrolled
OPTIMA
Phase 2 Completed
62 enrolled 13 charts
WISTERIA
Phase 1 Completed
9 enrolled
Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck
Phase 2 Completed
43 enrolled 16 charts
RT-CASinHNC
Completed
907 enrolled
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer
Phase 1 Completed
48 enrolled
Risk for Subsequent Osteoradionecrosis in A Transferred Fibula Flap in Head and Neck Cancer Patients Undergoing Segmental Mandibulectomy: a Cohort Study
Completed
580 enrolled
The Sinai Robotic Surgery Trial in HPV Positive Oropharyngeal Squamous Cell Carcinoma (SCCA) (SIRS TRIAL)
Phase NA Completed
112 enrolled 11 charts
Post-operative Radiation With Cetuximab for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck
Phase 2 Completed
24 enrolled 11 charts
ASOG-HNO1
Phase NA Completed
51 enrolled
DURTRE-RAD
Phase 2 Completed
18 enrolled
Pilot Study of Chemotherapy for HPV-Associated Oropharyngeal Cancer
Phase 1 Completed
50 enrolled
Cetuximab, Chemotherapy, and Radiation Therapy for Operable Stage III or IV Head and Neck Cancer
Phase 2 Completed
74 enrolled 8 charts
Phase II Study of Concurrent C225, Cisplatin and Radiation in Stage IV Squamous Cell Carcinoma of the Head and Neck
Phase 2 Completed
69 enrolled 7 charts
Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Larynx or Oropharynx Cancer
Phase 2 Completed
G-DEFINER
Completed
247 enrolled
BMX-HN
Phase 1/2 Completed
29 enrolled 14 charts
PembroRad
Phase 2 Completed
133 enrolled
Radiation Therapy Plan Quality Improvement Using Ideal Theoretical Isodose Distribution
Phase NA Completed
21 enrolled
Stereotactic Body Radiotherapy and Concurrent Cisplatin for Re-Irradiation of Unresectable, Recurrent Squamous Cell Carcinomas of Head and Neck
Phase 1 Completed
20 enrolled
Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer
Phase 3 Completed
111 enrolled 11 charts
IT-MATTERS
Phase 3 Completed
928 enrolled 25 charts
CisFRad
Phase 2 Completed
124 enrolled
Effectiveness of Adjuvant Radiotherapy in Small Oropharyngeal Squamous Cell Cancer and Single Lymph Node Metastasis.
Phase 3 Completed
209 enrolled
A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck Cancer
Phase 1/2 Completed
53 enrolled
NIMRAD
Phase 3 Completed
338 enrolled
Nivolumab or Nivolumab Plus Cisplatin, in Combination With Radiotherapy in Patients With Cisplatin-ineligible or Eligible Locally Advanced Squamous Cell Head and Neck Cancer
Phase 3 Completed
74 enrolled 19 charts
Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma
Phase 2 Completed
24 enrolled 16 charts
A Study of Chemoradiation Plus Pembrolizumab for Locally Advanced Laryngeal Squamous Cell Carcinoma
Phase 1/2 Completed
9 enrolled 11 charts
Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Advanced Cancer of the Oropharynx or Hypopharynx
Phase 3 Completed
160 enrolled